CD163 and tuberculosis: This finding is consistent with an up-regulation of the inflammatory chemokines CXCL9 and CXCL10 in TB/HIV co-infection (Supplemental Figure S1, B and C) and an enhanced tissue expression of the M2-marker CD163 in HIV-negative TB-infected patients (Figure 3, F and J).